Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Sees Significant Growth in Short Interest

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 3,548 shares, a growth of 31.0% from the January 29th total of 2,708 shares. Based on an average trading volume of 6,498 shares, the short-interest ratio is presently 0.5 days. Approximately 0.2% of the shares of the stock are sold short. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 6,498 shares, the short-interest ratio is presently 0.5 days.

Fidelity Disruptive Medicine ETF Trading Up 1.4%

Shares of Fidelity Disruptive Medicine ETF stock traded up $0.35 on Wednesday, reaching $25.92. 2,744 shares of the company were exchanged, compared to its average volume of 7,173. Fidelity Disruptive Medicine ETF has a fifty-two week low of $20.69 and a fifty-two week high of $29.07. The firm has a market capitalization of $59.62 million, a price-to-earnings ratio of 41.33 and a beta of 1.00. The stock has a fifty day moving average price of $26.78 and a 200-day moving average price of $26.35.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in FMED. Wealth Enhancement Advisory Services LLC grew its stake in Fidelity Disruptive Medicine ETF by 4.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 714,991 shares of the company’s stock valued at $19,712,000 after acquiring an additional 31,629 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Fidelity Disruptive Medicine ETF by 95.4% in the 4th quarter. Jane Street Group LLC now owns 91,414 shares of the company’s stock valued at $2,473,000 after purchasing an additional 44,630 shares during the last quarter. BXM Wealth LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the 4th quarter valued at $243,000. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF in the fourth quarter worth $234,000. Finally, Virtu Financial LLC acquired a new position in Fidelity Disruptive Medicine ETF during the fourth quarter worth $228,000.

About Fidelity Disruptive Medicine ETF

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.